[1]刁敏,吕小岩.Stevens-Johnson综合征和中毒性表皮坏死松解症的并发症及处理[J].中国皮肤性病学杂志,2019,(02):222-225.[doi:10.13735/j.cjdv.1001-7089.201804131]
 DIAO Min,LYU Xiaoyan.Complications and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J].The Chinese Journal of Dermatovenereology,2019,(02):222-225.[doi:10.13735/j.cjdv.1001-7089.201804131]
点击复制

Stevens-Johnson综合征和中毒性表皮坏死松解症的并发症及处理
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2019年02期
页码:
222-225
栏目:
综述
出版日期:
2019-02-01

文章信息/Info

Title:
Complications and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
作者:
刁敏吕小岩
四川大学华西医院,四川 成都 610041
Author(s):
DIAO MinLYU Xiaoyan
(Department of Dermatology,West China Hospital,Sichuan University,Chengdu 610041,China)
关键词:
Stevens-Johnson综合征 中毒性表皮坏死松解症 并发症 感染 抗生素
Keywords:
Stevens-Johnson syndrome Toxic epidermal necrolysis Complication Infection
分类号:
R 758.25
DOI:
10.13735/j.cjdv.1001-7089.201804131
文献标志码:
A
摘要:
Stevens-Johnson综合征(Stevens-Johnson syndrome,SJS)和中毒性表皮坏死松解症(toxic epidermal necrolysis,TEN)是重症药疹,病情严重可威胁生命。SJS/TEN患者急性期并发症多见,包括感染、多脏器受累、体液丢失与电解质紊乱、低蛋白血症等。本文主要从SJS和TEN的并发症包括感染、内脏损害及眼部受累方面进行综述,并简述相应的处理原则。
Abstract:
Stevens-Johnson syndrome and toxic epidermal necrolysis(TEN)are severe drug eruptions that can be life-threatening. Patients with SJS/TEN in the early stage are more likely to experience complications, including infections, multiple organ involvement, fluid loss and electrolyte disturbance and hypoproteinemia. This review summarizes the complications of SJS and TEN, including infections, visceral damage and ocular involvement, and briefly describes the corresponding principles of management.

参考文献/References:


[1] Bastuji-Garin S,Rzany B,Stern RS,et al.Clinical classification of cases of toxic epidermal necrolysis,Stevens-Johnson syndrome,and erythema multiforme[J].Arch Dermatol,1993,129(1):92-96.
[2] Tocco-Tussardi I,Huss F,Presman B.Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center[J].J Cutan Pathol,2017,44(5):420-432.
[3] Hermiz SJ,Diegidio P,Ortiz-Pujols S,et al.Life-threatening skin disorders treated in the Burn Center:impact of health care-associated infections on length of stay,survival,and hospital charges[J].Clin Plast Surg,2017,44(3):597-602.
[4] Mahar PD,Wasiak J,Cleland H,et al.Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patients[J].J Burn Care Res,2014,35(6):518-524.
[5] de Prost N,Ingen-Housz-Oro S,Duong T,et al.Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis:epidemiology,risk factors,and predictive value of skin cultures[J].Medicine(Baltimore),2010,89(1):28-36.
[6] Pinheiro S,Carvalho R,Ramos S,et al.Toxic epidermal necrolysis:the experience of Coimbra's burn unit[J].Acta Med Port,2013,26 (4):341-348.
[7] Sassolas B,Haddad C,Mockenhaupt M,et al.ALDEN,an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis:comparison with case-control analysis[J].Clin Pharmacol Ther,2010,88(1):60-68.
[8] Monteiro D,Egipto P,Barbosa J,et al.Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis(Lyell's syndrome)[J].Cutan Ocul Toxicol,2017,36(2):163-168.
[9] Weinand C,Xu W,Perbix W,et al.27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis:analysis of mortality risk for causative agents[J].Burns,2013,39(7):1449-1455.
[10] Horan TC,Andrus M,Dudeck MA.CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting[J].Am J Infect Control,2008,36(5):309-332.
[11] de Prost N,Mekontso-Dessap A,Valeyrie-Allanore L,et al.Acute respiratory failure in patients with toxic epidermal necrolysis [J].Crit Care Med,2014,42(1):118-128.
[12] Creamer D,Walsh SA,Dziewulski P,et al.UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016[J].J Plastic Reconstr Aesthet Surg,2016,69(6):e119-e153.
[13] Bequignon E,Duong TA,Sbidian E,et al.Stevens-Johnson syndrome and toxic epidermal necrolysis:ear,nose,and throat description at acute stage and after remission[J].JAMA Dermatol,2015,151(3):302-307.
[14] Saeed H,Mantagos IS,Chodosh J.Complications of Stevens-Johnson syndrome beyond the eye and skin[J].Burns,2016,42(1):20-27.
[15] Hung CC,Liu WC,Kuo MC,et al.Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis [J].Am J Nephrol,2009,29(6):633-638.
[16] Anathhanam S,Lewington AJ.Acute kidney injury[J].J R Coll Physicians Edinb,2013,43(4):323-328,329.
[17] Hu CH,Chang NJ,Liu EK,et al.SCORTEN and impaired renal function related to mortality oftoxic epidermal necrolysis syndrome patients in the Asian population[J].J Eur Acad Dermatol Venereol,2013,27(5):628-633.
[18] Devarbhavi H,Raj S,Aradya VH,et al.Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis:Patient characteristics,causes,and outcome in 36 cases[J].Hepatology,2016,63(3):993-999.
[19] 于乐成,茅益民,陈成伟.药物性肝损伤诊治指南[J].实用肝脏病杂志,2017,20(2):257-274.
[20] Basturk A,Artan R,Yilmaz A,et al.Acute vanishing bile duct syndrome after the use of ibuprofen[J].Arab J Gastroenterol,2016,17 (3):137-139.
[21] Okan G,Yaylaci S,Peker O,et al.Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus[J].World J Gastroenterol,2008,14(29):4697-4700.
[22] Harimoto N,Wang H,Ikegami T,et al.Education and imaging.Hepatology:Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen,requiring liver transplantation[J].J Gastroenterol Hepatol,2015,30(4):656.
[23] Juricic D,Hrstic I,Radic D,et al.Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man[J].Basic Clin Pharmacol Toxicol,2010,106(1):62-65.
[24] Garcia M,Mhanna MJ,Chung-Park MJ,et al.Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes[J].Dig Dis Sci,2002,47(1):177-182.
[25] White JC,Appleman S.Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis [J].Pediatrics,2014,134(4):e1194-e1198.
[26] Yamane Y,Matsukura S,Watanabe Y,et al.Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients - Treatment and outcome[J].Allergol Int,2016,65(1):74-81.
[27] Wang L,Mei XL.Retrospective analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese patients[J].Chin Med J(Engl),2017,130(9):1062-1068.
[28] Morales ME,Purdue GF,Verity SM,et al.Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN[J].Am J Ophthalmol,2010,150(4):505-510.
[29] Sotozono C,Ueta M,Nakatani E,et al.Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Am J Ophthalmol,2015,160(2):228-237.
[30] Chow L,Shih KC,Chan J,et al.Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes:a 15-year retrospective study[J].BMC Ophthalmol,2017,17(1):65.
[31] Gueudry J,Roujeau JC,Binaghi M,et al.Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Arch Dermatol,2009,145(2):157-162.
[32] Ciralsky JB,Sippel KC,Gregory DG.Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Curr Opin Ophthalmol,2013,24(4):321-328.
[33] Yang CW,Cho YT,Chen KL,et al.Long-term sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis[J].Acta Derm Venereol,2016,96(4):525-529.

相似文献/References:

[1]饶燕,陶春蓉.糖皮质激素联合免疫球蛋白治疗中毒性表皮坏死松解症25例临床观察[J].中国皮肤性病学杂志,2017,(02):165.[doi:10.13735/j.cjdv.1001-7089.201605112]
 RAO Yan,TAO Chun-rong.Combination of Intravenous Glucocorticoid and Immunoglobulin in Treatment of Toxic Epidermal Necrolysis: a Comparative Study in Twenty-five Cases[J].The Chinese Journal of Dermatovenereology,2017,(02):165.[doi:10.13735/j.cjdv.1001-7089.201605112]
[2]平晓芳,卢桂玲.重症多形红斑型药疹52例和中毒性表皮坏死松解症31例回顾性分析[J].中国皮肤性病学杂志,2013,(02):148.
[3]韩锋,王晓鹏,安金刚,等.复方黄柏液湿敷治疗中毒性表皮坏死松解症的临床疗效观察[J].中国皮肤性病学杂志,2019,(02):248.[doi:10.13735/j.cjdv.1001-7089.201801156]
 HAN Feng,WANG Xiaopeng,AN Jingang,et al.Clinical Efficacy of External Application of Compound Huangbai Solution in the Treatment of Toxic Epidermal Necrosis[J].The Chinese Journal of Dermatovenereology,2019,(02):248.[doi:10.13735/j.cjdv.1001-7089.201801156]

备注/Memo

备注/Memo:

[作者单位] 四川大学华西医院,四川 成都 610041
[通讯作者] 吕小岩,E-mail:clazhou@126.com
更新日期/Last Update: 2019-01-20